Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
BMS fosters biotech in Kendall Square
by Lisa M. Jarvis
March 14, 2016
| A version of this story appeared in
Volume 94, Issue 11
Bristol-Myers Squibb has become a sponsor at LabCentral, a shared laboratory space in Cambridge, Mass., for biotech start-ups. The sponsorship will allow BMS to nominate two start-ups each year for a spot at LabCentral’s Kendall Square facilities; winners of the two so-called Golden Tickets will receive underwritten bench space for one scientist for one year and a priority spot on the waiting list for more space. BMS’s support of start-ups in the Boston area comes as the company builds a research facility in Kendall Square set to open in early 2018.
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X